Richard Lehman’s Journal Review – October 2011

BMJ Group blogs: BMJ » Blog Archive » Richard Lehman’s journal review – 3 October 2011

BMJ Group blogs: BMJ » Blog Archive » Richard Lehman’s journal review – 10 October 2011

BMJ Group blogs: BMJ » Blog Archive » Richard Lehman’s journal review – 17 October 2011

BMJ Group blogs: BMJ » Blog Archive » Richard Lehman’s journal review – 24 October 2011

Here are the links.  Happy reading.

Quiet Please…Life Underwriting Expert Witness Personal Branding Exercise in Progress

Only Your Brand Will Save You – Dorie Clark – Harvard Business Review

Starting today, think about how you can own your niche and build your audience. If you care about insuring yourself against hard times, the only true safety is in developing a personal brand that’s better known — and therefore more powerful — than that of your competitors, or even your employer.

Olanzapine – Think Bipolar and Schizophrenia

Medical News: FDA Okays Generic Version of Zyprexa – in Psychiatry, Schizophrenia from MedPage Today

The FDA has approved a generic version of atypical antipsychotic drug olanzapine (Zyprexa) to treat schizophrenia and bipolar disorder.

According to the AP story:

Drugs like Zyprexa can cost up to $500 per month. Generic versions can cut the cost by up to 80 percent.

This is great news.

Scary Chart of the Day 10.21.11

 

Economist’s View: “First Look at US Pay Data, It’s Awful”

The median paycheck — half made more, half less — fell again in 2010, down 1.2 percent to $26,364. That works out to $507 a week, the lowest level, after adjusting for inflation, since 1999.

A VERY Scary Chart

I had gotten away from posting Scary Charts.  There were just too many to pick from.  But when I came across this graphic, well I just had to post it.